Mark Sabag

2017

In 2017, Mark Sabag earned a total compensation of $2.5M as Executive Vice President, Global Human Resources at Teva Pharmaceutical Industries.

Compensation breakdown

Option Awards$533,375
Salary$604,637
Stock Awards$1,066,630
Other$317,108
Total$2,521,750

Sabag received $1.1M in stock awards, accounting for 42% of the total pay in 2017.

Sabag also received $533.4K in option awards, $604.6K in salary and $317.1K in other compensation.

Rankings

In 2017, Mark Sabag's compensation ranked 4,383rd out of 14,666 executives tracked by ExecPay. In other words, Sabag earned more than 70.1% of executives.

ClassificationRankingPercentile
All
4,383
out of 14,666
70th
Division
Manufacturing
1,542
out of 5,768
73rd
Major group
Chemicals And Allied Products
445
out of 2,074
79th
Industry group
Drugs
341
out of 1,730
80th
Industry
Pharmaceutical Preparations
269
out of 1,329
80th
Source: SEC filing on April 25, 2018.

Sabag's colleagues

We found nine more compensation records of executives who worked with Mark Sabag at Teva Pharmaceutical Industries in 2017.

2017

Kåre Schultz

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Yitzhak Peterburg

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Rob Koremans

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Carlo de Notaristefani

Teva Pharmaceutical Industries

Executive Vice President, Global Operations

2017

Michael Hayden

Teva Pharmaceutical Industries

Chief Scientific Officer

2017

Eyal Desheh

Teva Pharmaceutical Industries

Chief Financial Officer

2017

Hafrun Fridriksdottir

Teva Pharmaceutical Industries

Executive Vice President, Global Research and Development

2017

Erez Vigodman

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Michael McClellan

Teva Pharmaceutical Industries

Chief Financial Officer

News

You may also like